Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ARENA PHARMACEUTICALS INC (0001080709)
Standardized SEC financial data for ARENA PHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001080709 · Pharmaceutical Preparations.
Income statement
USD
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
Revenue
$92.2M
$21.3M
$18.0M
$806.4M
$319K
$54K
Cost of revenue
$9.3M
—
—
—
—
—
Gross profit
$82.9M
—
—
—
—
—
R&D expense
$63.8M
$71.0M
$115.0M
$231.5M
$323.7M
$419.5M
SG&A expense
$27.5M
$30.3M
$45.3M
$77.6M
$103.2M
$126.2M
Operating income
-$5.3M
-$92.0M
-$144.8M
$482.7M
-$426.6M
-$624.3M
EBITDA
-$269K
-$87.7M
-$141.0M
$486.0M
-$422.8M
-$620.4M
Interest expense
$6.5M
$6.1M
$5.7M
$4.8M
$4.5M
$4.2M
Pretax income
-$22.5M
-$95.9M
-$138.8M
$507.9M
-$404.7M
-$616.4M
Income tax
$0
$0
$110.3M
$110.3M
$0
$0
Net income
-$22.5M
-$91.4M
-$29.4M
$397.6M
-$404.7M
-$616.4M
EPS (diluted)
—
$-2.77
$-0.63
$7.69
$-7.39
$-10.14
Standardized from ARENA PHARMACEUTICALS INC's SEC filings — per-share figures split-adjusted. Full history via the API.